Skip to main content
SpringerLink
Log in

Gynecological Carcinosarcomas

  • Chapter
  • First Online:
Ovarian Cancers

  • 1042 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Amant F, Cadron I, Fuso L, Berteloot P, de Jonge E, Jacomen G, et al. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol Oncol. 2005;98:274–80.

    Article  PubMed  Google Scholar 

  2. FIGO Committee on Gynecologic Oncology. FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. Int J Gynaecol Obstet. 2014;125(2):97–8.

    Article  Google Scholar 

  3. D’Angelo E, Prat J. Pathology of mixed Müllerian tumours. Best Pract Res Clin Obstet Gynaecol. 2011;25(6):705–18.

    Article  PubMed  Google Scholar 

  4. Sreenan JJ, Hart WR. Carcinosarcomas of the female tract. A pathological study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol. 1995;19:666–74.

    Article  CAS  PubMed  Google Scholar 

  5. Gorai I, Yanagibashi T, Taki A, Udagawa K, Miyagi E, Nakazawa T, Hirahara F, Nagashima Y, Minaguchi H. Uterine carcinosarcoma is derived from a single stem cell: an in vitro study. Int J Cancer. 1997;72:821–7.

    Article  CAS  PubMed  Google Scholar 

  6. Fujii H, Yoshida M, Gong ZX, Matsumoto T, Hamano Y, Fukunaga M, Hruban RH, Gabrielson E, Shirai T. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotic diversity. Cancer Res. 2000;60:114–20.

    CAS  PubMed  Google Scholar 

  7. Amant F, Vloeberghs V, Woestenborghs H, Moerman P, Vergote I. Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis. Gynecol Oncol. 2003;90:372–7.

    Article  PubMed  Google Scholar 

  8. Tanaka Y, Terai Y, Kawaguchi H, Fujiwara S, Yoo S, Tsunetoh S, Takai M, Kanemura M, Tanabe A, Ohmichi M. Prognostic impact of EMT(epithelial-mesenchymal-transition)-related protein expression in endometrial cancer. Cancer Biol Ther. 2013;14(1):13–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Murray S, Linardou H, Mountzios G, Manokoulos M, Markaki S, Eleutherakis-Papaiakovou E, Dimopoulos MA, Papadimitriou CA. Low frequency of somatic mutations in uterine sarcomas: a molecular analysis and review of the literature. Mutat Res. 2010;686:68–73.

    Article  CAS  PubMed  Google Scholar 

  10. De Jong RA, Nijman HW, Wilbrandi TF, Reyners AK, Boezen HM, Hollema H. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial component. Mol Pathol. 2011;24(10):1368–79.

    Article  Google Scholar 

  11. Growdon W, Roussel B, Scialabba V, Foster R, Dias-Santagata D, Iafrate A, Ellisen L, Tambouret R, Rueda B, Borger D. Tissue-specific signatures of activating PI3CA and RAS mutations in carcinosarcomas of gynecologic origin. Gynecol Oncol. 2011;121:212–7.

    Article  CAS  PubMed  Google Scholar 

  12. Cimbaluk D, Rotmensch J, Scudiere J, Gown A, Bitterman P. Uterine carcinosarcoma: Immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets. Gynecol Oncol. 2007;105:138–44.

    Article  CAS  PubMed  Google Scholar 

  13. Garg G, Shah J, Kumar S, Bryant C, Munkarah A, Morris R. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes. Int J Gynecol Cancer. 2010;20:888–94.

    Article  PubMed  Google Scholar 

  14. Rauh-Hain JA, Shoni M, Shorge JO, Goodman A, Horowitz N, Del Carmen M. Prognostic determinants in patients with uterine and ovarian carcinosarcomas. J Reprod Med. 2013;58:297–304.

    PubMed  Google Scholar 

  15. Ferguson SE, Tornos C, Hummer A, Barakat RR, Soslow RA. Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol. 2007;31(11):1653–61.

    Article  PubMed  Google Scholar 

  16. Rauh-Hain JA, Growdon WB, Rodriguez N, Goodman AK, Boruta II DM, Schorge JO, Horowitz NS, Del Carmen MG. Carcinosarcoma of the ovary: a case control study. Gynecol Oncol. 2011;121:477–81.

    Article  PubMed  Google Scholar 

  17. Nemani D, Mitra N, Guo M, et al. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol. 2008;III:82–8.

    Article  Google Scholar 

  18. Vorgias G, Fotiou S. The role of lymphadenectomy in uterine carcinomas: a critical literature review Arch. Gynecol Obstet. 2010;282:659–64.

    CAS  Google Scholar 

  19. Tanner EJ, Leitao Jr MM, Garg K. The role of cytoreductive surgery for newly diagnosed-stage uterine carcinosarcoma. Gynecol Oncol. 2011;25:751–60.

    Google Scholar 

  20. Reed NS, Mangioni C, Malmstrom H, et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy III the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer. 2008;44:808–18 [Erratum appears in Eur J Cancer. 2008;44:1612].

    Article  CAS  PubMed  Google Scholar 

  21. Wright JD, Seshan VE, Shah M, Schiff PB, Burke WM, Cohen CJ, Herzog TJ. The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma. Am J Obstet Gynecol. 2008;199(5):531–8.

    Article  Google Scholar 

  22. Clayton Smith D, Kenneth Macdonald O, Gaffney DK, et al. The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma. Radiother Oncol. 2008;88:227–32.

    Article  CAS  PubMed  Google Scholar 

  23. Wolfson AH, Brady MF, Rocereto T, Mannel RS, Lee YC, Futoran RJ, et al. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus. Gynecol Oncol. 2007;107:177–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Omura GA, Major FJ, Blessing JA, Sedlacek TV, Thigpen JT, Creasman WT, et al. A randomized study of adriamycin with and without dimethyl triazenoimidazolecarboxamide in advanced uterine sarcomas. Cancer. 1983;52:626–32.

    Article  CAS  PubMed  Google Scholar 

  25. Pautier P, Floquet A, Gladieff L, et al. A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). Ann Oncol. 2013;24(4):1099–104.

    Article  CAS  PubMed  Google Scholar 

  26. Sutton G, Kauderer J, Carson LF, Lentz SS, Whitney CW, Gallion H. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol. 2005;96:630–4.

    Article  CAS  PubMed  Google Scholar 

  27. Powell MA, Filiaci VL, Rose PG, Mannel RS, Hanjani P, DeGeest K, et al. Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group Study. J Clin Oncol. 2010;28:2727–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Makker V, Abu-Rustum NR, Alektiar KM, et al. A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma. Gynecol Oncol. 2008;3:249–54.

    Article  Google Scholar 

  29. NCCN Guidelines Version 3.2012 Endometrial carcinoma. http://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf. Accessed on 19 Sept 2012.

  30. Duska LR, Garett A, Eltabbakh MD, Oliva E, Penson R, Fuller A. Paclitaxel and Platinum Chemotherapy for malignant mixed mullerian tumors of the ovary. Gynecol Oncol. 2002;85:459–63.

    Article  CAS  PubMed  Google Scholar 

  31. Shylasree TS, Bryant A, Athavale R. Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma. Cochrane Database Syst Rev. 2013;2:CD006246.

    Google Scholar 

  32. Homesley HD, Filiaci V, Markman M, Bitterman P, Eaton L, Kilgore LC, et al. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:526–31.

    Article  CAS  PubMed  Google Scholar 

  33. Sutton G, Brunetto VL, Kilgore L, Soper JT, McGehee R, Olt G, et al. Trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol. 2000;79:147–53.

    Article  CAS  PubMed  Google Scholar 

  34. Morrow CP, Bundy BN, Hoffman J, Sutton G, Homesley H. Adriamycin chemotherapy for malignant mixed mesodermal tumor of the ovary. A Gynecologic Oncology Group Study. Am J Clin Oncol. 1986;9(1):24–6.

    Article  CAS  PubMed  Google Scholar 

  35. Pectasides D, Pectasides E, Papaxoinis G, Xiros N, Sykiotis C, Papachristodoulou A, Tountas N, Panayiotides J, Economopoulos T, et al. Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution. Gynecol Oncol. 2008;110:299–303.

    Article  CAS  PubMed  Google Scholar 

  36. Galaal K, van der Heijden E, Godfrey K, et al. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. Cochrane Database Syst Rev. 2013;2:CD006812.

    Google Scholar 

  37. Hoskins PI, Le N, Ellard S, et al. Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience. Gynecol Oncol. 2008;108:58–62.

    Article  CAS  PubMed  Google Scholar 

  38. Huh WK, Sill MW, Darcy KM, et al. Efficacy and safety of imatinib mesylate (Gleevec®) and immunohistochemical expression of c-Kit and PDGFR-β in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus. Gynecol Oncol. 2010;117:248–54.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ICO Centre René Gauducheau, Saint Herblain, France

    D. Berton-Rigaud & J. S. Frenel

  2. Centre Hospitalier Universitaire Lyon Sud, Lyon, France

    M. Devouassoux-Shisheboran

  3. Centre Leon Bérard, Lyon, France

    I. Ray-Coquard

Authors
  1. D. Berton-Rigaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. S. Frenel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Devouassoux-Shisheboran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Ray-Coquard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Berton-Rigaud .

Editor information

Editors and Affiliations

  1. AP-HP, Hôtel-Dieu, Paris, France

    Eric Pujade-Lauraine

  2. Centre Léon Bérard, Université Claude Bernard, Lyon, France

    Isabelle Ray-Coquard

  3. Chirurgie cancérologique, HEGP, Paris, France

    Fabrice Lécuru

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Berton-Rigaud, D., Frenel, J.S., Devouassoux-Shisheboran, M., Ray-Coquard, I. (2017). Gynecological Carcinosarcomas. In: Pujade-Lauraine, E., Ray-Coquard, I., Lécuru, F. (eds) Ovarian Cancers. Springer, Cham. https://doi.org/10.1007/978-3-319-32110-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32110-3_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32108-0

  • Online ISBN: 978-3-319-32110-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation